DARE Logo

Urology


The Urology and Urologic Oncology specialty research group strives to facilitate investigations focused on improving clinical outcomes centered on patient care and how to implement changes in the care of our patients. Current topic areas of interest include: refining prostate cancer screening / detection strategies, utility of prostate MRI in men with prior negative biopsies, predicting response of neoadjuvant chemotherapy for invasive bladder cancer, optimizing clinical care of testicular cancer patients, use of outpatient TURP, impact of a regional kidney stone prevention program.


Physicians Involved in Research

Ongoing and Completed Urology Projects, All Funding Mechanisms

Development, Validation and Initial Implementation of the Kaiser Permanente Prostate Cancer Risk Calculator 2.0 in Men with a Prior Negative Biopsy
Joseph Presti, Andrew Avins | Urology | DSGP | Ongoing

Prediction of Postoperative Urinary Retention in a Large Integrated Health System
Langston, Marvin PhD | Urology | CB | Ongoing

Refining Shared Decision Making in Prostate Cancer Screening and Detection
Joseph Presti | Urology | PRP | Ongoing

Changing physician PSA screening behavior in men 70 years of age and older by use of the EMR
Joe Presti, Stacey Alexeef, Brandon Horton, Stephanie Prausnitz, Andy Avins. | Urology | PRP | Completed

Development of the Kaiser prostate cancer risk calculator
Joe Presti, Stacey Alexeef, Brandon Horton, Stephanie Prausnitz, Andy Avins. | Urology | PRP | Completed

Identify predictors of pathologic complete response to neoadjuvant chemotherapy for muscle invasive bladder cancer.
Andrea Harzstark | Urology | CB | Completed

Impact of 2012 USPSTF statement on prostate cancer screening and detection in men under the age of 70 at KPNC
Joe Presti, Stacey Alexeef, Brandon Horton, Stephanie Prausnitz, Andy Avins. " | Urology | PRP | Completed

Impact of Metformin use on benign prostatic hyperplasia.
Gene Seto | Urology | CB | Completed

Prospective Validation of the Kaiser Permanente Prostate Cancer Risk Calculator
Joe Presti | Urology | CB | Completed

Significance of borderline high and high serum calcium levels in high risk kidney stone patients in a community practice. Emphasis on high normal serum calcium levels
Mark Gasparini, Stephen Van Den Eeden | Urology | TAP | Completed

Vitamin D Supplementation and Kidney Stone Risk
Gene Seto | Urology | CB | Completed